Non-Binary Embodiment, Queer Knowledge Production, and Disrupting the Cisnormative Field: Notes From a Trans Ethnographer
The Journal of Men’s Studies · 2022-10 · 30 (3) · 425-445
DOI: 10.1177/10608265221108204 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Men’s Studies, online erschienen am 10.06.2022. Verfasst von Brandon Andrew Robinson. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In this article, I show how my non-binary embodiment, along with regularly being misgendered, shapes the questions I ask, the research I conduct, the data I can gather, how I understand my research and data, and the knowledge I produce. Through this interrogation of my body in relation to research methods and epistemologies, I illuminate how trans and non-binary scholars disrupt the cisnormative assumptions of ethnographic fieldwork, of sociology, and of academia. These disruptions generate queer forms of knowledge production that center trans and non-binary experiences and perspectives and that move us toward thinking anew about researchers, embodiment, and methods, and their epistemological effects.
Zitieren
APA
Robinson, B. A. (2022). Non-Binary Embodiment, Queer Knowledge Production, and Disrupting the Cisnormative Field: Notes From a Trans Ethnographer. The Journal of Men’s Studies, 30(3), 425-445. https://doi.org/10.1177/10608265221108204
Vancouver
Robinson BA. Non-Binary Embodiment, Queer Knowledge Production, and Disrupting the Cisnormative Field: Notes From a Trans Ethnographer. The Journal of Men’s Studies. 2022;30(3):425-445. doi:10.1177/10608265221108204
BibTeX
@article{Robinson2022,
author = {Robinson, Brandon Andrew},
title = {Non-Binary Embodiment, Queer Knowledge Production, and Disrupting the Cisnormative Field: Notes From a Trans Ethnographer},
journal = {The Journal of Men’s Studies},
year = {2022},
volume = {30},
number = {3},
pages = {425--445},
doi = {10.1177/10608265221108204}
}
EUVIMED